CONNECT WITH US

Web3 & Blockchain

Coinbase Co-Founder’s Longevity Startup NewLimit Raises $435M for Human Trials

Coinpedia - Blockchain logo

Published on

Coinbase Co-Founder’s Longevity Startup NewLimit Raises $435M for Human Trials

The post Coinbase Co-Founder’s Longevity Startup NewLimit Raises $435M for Human Trials appeared first on Coinpedia Fintech News

NewLimit, a longevity biotechnology company co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in a Series C funding round led by Founders Fund. New investors, including Thrive Capital, Greenoaks and Quiet Capital, joined existing backers such as Kleiner Perkins and Eli Lilly Ventures. The company develops age-reprogramming therapies designed to restore cell function …



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Google Preferred Source